TrialPath
Recruiting

Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

NCT07454733 · Trustees of Dartmouth College
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Comparing the Impact of Video Integration to Traditional Amyotrophic Lateral Sclerosis Visit Communication on Patient and Caregiver Quality of Life
About this study
BACKGROUND AND SIGNIFICANCE Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. People with ALS (pwALS) and their caregivers, attend 3 - 5 hour long multidisciplinary clinics (MDC) every 3 months where they meet with up to 12 specialists. The goal of treatment is to maintain pwALS quality of life (QOL). Optimal information from MDCs is necessary for the intensive at-home management which gets more complex as ALS progresses. Yet 40% of recommendations are forgotten by pwALS negatively impacting QOL, while caregivers report information deficits increasing caregiving burden. Patient portal access to MDC notes is standard, and can improve recall and health outcomes, yet concerns exist about their layout, comprehensiveness and challenges for people with low health literacy. An underutilized strategy to share MDC information is video recording. Systematic reviews find recordings improve health outcomes, and the use of video in an ALS context may be particularly helpful given complicated at-home management. The study will determine what is the most effective approach to communicating MDC information to facilitate optimal delivery of care for pwALS and their caregivers STUDY AIMS Aim 1. Assess the comparative effectiveness of written MDC visit information provided to pwALS and their caregivers via the patient portal (NOTES) versus NOTES plus visit video recording (VIDEO) on patient and caregiver quality of life. Aim 2. Determine whether patient and caregiver health literacy and rapid ALS disease progression are modifying factors on the comparative effectiveness of NOTES versus VIDEO on primary outcomes. Aim 3. Identify system and patient-level factors that impact the implementation and use of multimodal strategies of MDC information exchange by a diverse sample of pwALS, caregivers, clinicians and health system leaders. Hypothesis (Main Effect): Compared to those receiving NOTES, pwALS randomized to also receive routine VIDEO recordings of their MDC visit will report better QOL via improved care-management (i.e., treatment adherence), self-management ability, satisfaction with communication and reduced healthcare utilization at 12 months; there will be larger relative benefits for pwALS, and caregivers, with low health literacy and rapid disease progression. The investigators also hypothesize that compared to NOTES alone, caregivers in the VIDEO arm will report better QOL, improved preparedness and less burden at 12 months. STUDY DESCRIPTION Overall study design This study is a multisite, two-arm, parallel group, patient-randomized, controlled, comparative effectiveness trial with 12-month follow-up. Adopting a Hybrid Type 1 design, the investigators will also examine implementation barriers and facilitators using interviews guided by the Consolidated Framework for Implementation Research Framework 2.0. Comparators Comparator 1 (NOTES): After the initial MDC study staff will provide a 15-minute training to orient participants to the portal and how to access visit notes. Comparator 2 (VIDEO): All MDC visits will be video-recorded over 12 months, using HealthPAL, an NIH-funded HIPAA-compliant personal health library developed by PI Barr. Participants in the VIDEO arm will receive orientation to the patient portal and HealthPAL. Following each scheduled MDC, pwALS and caregivers in both groups will receive emails reminding them to watch the visit video recording and/or review their note: 1) within 48 hours of the visit to remind them of the visit discussion and self-management tasks they may have; and 2) 3 days before their next MDC visit to prepare for their next MDC visit. Study Population The study recruit 400 patient and caregiver pairs (400 pwALS and their 400 caregivers) from eight MDC sites (∼50 pairs per site): Dartmouth Health (Lebanon, NH), Massachusetts General Hospital (Boston, MA), Mayo Clinics (Scottsdale, AZ, and Jacksonville, FL), Penn State Health (Hershey, PA), University of Pittsburgh Medical Center (Pittsburgh, PA), University of Wisconsin (Madison, WI) and Virginia Commonwealth University (Richmond, VA). The study will include pwALS, age ≥18 years, who plan to attend MDC visits for 12-months, speak English or Spanish, have ≥12 months projected survival, and internet access and their primary caregivers (family member or friend), ≥18 years who attends MDC visits or assist with their care. Outcomes Primary outcomes: For people with ALS, the total score on the ALSAQ-40 (a self report survey measure of quality of life for people with ALS) is the primary outcome. For caregivers, the total score on the PROMIS-10 (a self report survey measure of quality of life); Secondary outcomes include exercise adherence, medication adherence, adherence to MDC recommendations, self-management ability, patient satisfaction with communication, caregiver visit engagement, preparedness for caregiving, and caregiver burden. Exploratory outcomes include healthcare utilization. Timeframe Twelve-month follow-up for all outcomes.
Eligibility criteria
Inclusion Criteria for People with ALS: * Diagnosis of ALS by either El- Escorial or Gold Coast Criteria * ≥18 years of age * Plan to attend MDC visits for 12 months * Speak English or Spanish * Presence of a caregiver (defined as someone who assists with care) who is also participating in the VITALS trial * Projected life expectancy of at least 12 months as determined by the site investigator. Exclusion Criteria for People with ALS: * Unable or unwilling to provide informed consent or follow study procedures * Significant cognitive impairment, clinical dementia, or unstable psychiatric illness (including, but not limited to, psychosis, active suicidal ideation, suicide attempt, or untreated major depression) as determined by the site investigator * Current pregnancy based on participant self-report; * Unable to access the internet; * Do not have access to a personal or shared email and are not interested in creating a personal or shared email; * Do not wish to create a patient portal account, if they do not already have one; * Uncorrected hearing or visual impairment that would impair the ability to view video recordings; * Incarcerated. Inclusion Criteria for Caregivers: * Agree to their identified role as a caregiver of a patient with ALS participating in the VITALS trial; * Speak English or Spanish; * ≥18 years of age. Exclusion Criteria for Caregivers: * Unable or unwilling to provide consent or follow study procedures; * Unable to access the internet; * Do not have access to a personal or shared email and are not interested in creating a personal or shared email; * Uncorrected hearing or visual impairment; * Professional caregiver for the patient; * Incarcerated.
Study design
Enrollment target: 800 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2026-08-12
Estimated completion: 2029-10-01
Last updated: 2026-10-08
Interventions
Behavioral: Video recordingBehavioral: Notes Instruction
Primary outcomes
  • • For Caregiver Participants: the total score on the PROMIS-10 self report survey (Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.)
  • • For Patient Participants: The total score on the ALSAQ-40 self report survey. (Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.)
Sponsor
Trustees of Dartmouth College · other
With: Patient-Centered Outcomes Research Institute, Massachusetts General Hospital, Dartmouth-Hitchcock Medical Center, University of Pittsburgh Medical Center, Penn State Health Milton S Hershey Medical Center, University of Wisconsin, Madison, Mayo Clinic
Contacts & investigators
ContactPaul J Barr, PhD · contact · paul.j.barr@dartmouth.edu · 603-646-7016
ContactKelly M Goedert, PhD · contact · kelly.m.goedert@dartmouth.edu · 603-646-6976
InvestigatorPaul J Barr, PhD · principal_investigator, Dartmouth College
InvestigatorSuma Babu, MD · principal_investigator, Massachusetts General Hospital
All locations (7)
Mayo Clinic ScottsdaleNot Yet Recruiting
Scottsdale, Arizona, United States
Mayo Clinic JacksonvilleNot Yet Recruiting
Jacksonville, Florida, United States
Massachusetts General HospitalNot Yet Recruiting
Boston, Massachusetts, United States
Dartmouth-Hitchcock HealthRecruiting
Lebanon, New Hampshire, United States
Penn State Health Milton S. Hersey Medical CenterNot Yet Recruiting
Hershey, Pennsylvania, United States
University of Pittsburgh Medical CenterNot Yet Recruiting
Pittsburgh, Pennsylvania, United States
University of Wisconsin HealthNot Yet Recruiting
Madison, Wisconsin, United States
Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers? · TrialPath